Learning Early Infant Feeding Cues

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age2+
SponsorFlorida State University

About this trial

The goal of this clinical trial is to learn more about responsive infant feeding (recognizing baby's signs of hunger and fullness) in mothers and infant enrolled in government-funded maternal-child home visiting programs. The main questions it aims to answer are:

* What are the contributors and barriers to use of responsive infant feeding? * How can we refine an intervention focused on responsive infant feeding (the Learning Early Infant Feeding Cues intervention) so that mothers will like it and learn skills to help their baby be healthy. * Will the refined intervention improve use of responsive feeding and be feasible and acceptable to mothers and home visiting programs?

Participants will be asked to:

* Participate in focus groups to talk about their experiences feeding their baby. * Participate in a study to learn about responsive feeding and how to use it with their baby. This study will start when mothers are in their final month of pregnancy and finish when their baby is 6 months old. Participation will include:

* Having someone come to the family home during a time when the baby is eating (either from the breast or the bottle). The mother will receive information on the baby's signs from an experienced coach. * Agreeing to be video recording during the session when the baby is eating. * Completing surveys online.

Eligibility criteria

Qualifiers

Enrolled in a government-funded maternal-child home visiting program

Maternal age 18 years or older

English or Spanish speaking

Anticipated to have custody of infant after birth

Disqualifiers

Gave birth to multiple fetuses

Age less than 18 years

Not fluent in English or Spanish

Expected to not have custody of the infant after birth

Trial design

Treatments tested in this trial

  • Learning Early Infant Feeding Cues

Treatment groups

39 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators